Association of Disease‐Specific Health Status With Long‐Term Survival in Peripheral Artery Disease

Background While peripheral artery disease (PAD) is associated with increased cardiovascular morbidity with mortality remaining high and challenging to predict, accurate understanding of serial PAD‐specific health status around the time of diagnosis may prognosticate long‐term mortality risk. Method...

Full description

Bibliographic Details
Main Authors: Andy T. Tran, John A. Spertus, Carlos I. Mena‐Hurtado, Philip G. Jones, Herbert D. Aronow, David M. Safley, Ali O. Malik, Poghni A. Peri‐Okonny, Mehdi H. Shishehbor, Clementine Labrosciano, Kim G. Smolderen
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.022232
_version_ 1797859014929809408
author Andy T. Tran
John A. Spertus
Carlos I. Mena‐Hurtado
Philip G. Jones
Herbert D. Aronow
David M. Safley
Ali O. Malik
Poghni A. Peri‐Okonny
Mehdi H. Shishehbor
Clementine Labrosciano
Kim G. Smolderen
author_facet Andy T. Tran
John A. Spertus
Carlos I. Mena‐Hurtado
Philip G. Jones
Herbert D. Aronow
David M. Safley
Ali O. Malik
Poghni A. Peri‐Okonny
Mehdi H. Shishehbor
Clementine Labrosciano
Kim G. Smolderen
author_sort Andy T. Tran
collection DOAJ
description Background While peripheral artery disease (PAD) is associated with increased cardiovascular morbidity with mortality remaining high and challenging to predict, accurate understanding of serial PAD‐specific health status around the time of diagnosis may prognosticate long‐term mortality risk. Methods and Results Patients with new or worsening PAD symptoms enrolled in the PORTRAIT Registry across 10 US sites from 2011 to 2015 were included. Health status was assessed by the Peripheral Artery Questionnaire (PAQ) Summary score at baseline, 3‐month, and change from baseline to 3‐month follow‐up. Kaplan‐Meier using 3‐month landmark and hierarchical Cox regression models were constructed to assess the association of the PAQ with 5‐year all‐cause mortality. Of the 711 patients (mean age 68.8±9.6 years, 40.9% female, 72.7% white; mean PAQ 47.5±22.0 and 65.9±25.0 at baseline and 3‐month, respectively), 141 (19.8%) died over a median follow‐up of 4.1 years. In unadjusted models, baseline (HR, 0.90 per‐10‐point increment; 95% CI, 0.84–0.97; P=0.008), 3‐month (HR [95% CI], 0.87 [0.82–0.93]; P<0.001) and change in PAQ (HR [95% CI], 0.92 [0.85–0.99]; P=0.021) were each associated with mortality. In fully adjusted models including combination of scores, 3‐month PAQ was more strongly associated with mortality than either baseline (3‐month HR [95% CI], 0.85 [0.78–0.92]; P<0.001; C‐statistic, 0.77) or change (3‐month HR [95% CI], 0.79 [0.72–0.87]; P<0.001). Conclusions PAD‐specific health status is independently associated with 5‐year survival in patients with new or worsening PAD symptoms, with the most recent assessment being most prognostic. Future work is needed to better understand how this information can be used proactively to optimize care.
first_indexed 2024-04-09T21:22:38Z
format Article
id doaj.art-5a137f8c597c41e4bf76e091d87b0cd4
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-09T21:22:38Z
publishDate 2022-02-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-5a137f8c597c41e4bf76e091d87b0cd42023-03-28T04:20:06ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802022-02-0111410.1161/JAHA.121.022232Association of Disease‐Specific Health Status With Long‐Term Survival in Peripheral Artery DiseaseAndy T. Tran0John A. Spertus1Carlos I. Mena‐Hurtado2Philip G. Jones3Herbert D. Aronow4David M. Safley5Ali O. Malik6Poghni A. Peri‐Okonny7Mehdi H. Shishehbor8Clementine Labrosciano9Kim G. Smolderen10Department of Medicine University of California Irvine School of Medicine Orange CACardiovascular Research Saint Luke’s Mid America Heart Institute Kansas City MOVascular Medicine Outcomes Program Section of Cardiovascular Medicine Department of Internal Medicine Yale University New Haven CTCardiovascular Research Saint Luke’s Mid America Heart Institute Kansas City MODepartment of Medicine Alpert Medical School of Brown University Providence RICardiovascular Research Saint Luke’s Mid America Heart Institute Kansas City MOCardiovascular Research Saint Luke’s Mid America Heart Institute Kansas City MOCardiovascular Research Saint Luke’s Mid America Heart Institute Kansas City MOInterventional Cardiovascular Center Case Western Reserve University School of Medicine Cleveland OHThe Queen Elizabeth Hospital Adelaide Medical School University of Adelaide SA AustraliaVascular Medicine Outcomes Program Section of Cardiovascular Medicine Department of Internal Medicine Yale University New Haven CTBackground While peripheral artery disease (PAD) is associated with increased cardiovascular morbidity with mortality remaining high and challenging to predict, accurate understanding of serial PAD‐specific health status around the time of diagnosis may prognosticate long‐term mortality risk. Methods and Results Patients with new or worsening PAD symptoms enrolled in the PORTRAIT Registry across 10 US sites from 2011 to 2015 were included. Health status was assessed by the Peripheral Artery Questionnaire (PAQ) Summary score at baseline, 3‐month, and change from baseline to 3‐month follow‐up. Kaplan‐Meier using 3‐month landmark and hierarchical Cox regression models were constructed to assess the association of the PAQ with 5‐year all‐cause mortality. Of the 711 patients (mean age 68.8±9.6 years, 40.9% female, 72.7% white; mean PAQ 47.5±22.0 and 65.9±25.0 at baseline and 3‐month, respectively), 141 (19.8%) died over a median follow‐up of 4.1 years. In unadjusted models, baseline (HR, 0.90 per‐10‐point increment; 95% CI, 0.84–0.97; P=0.008), 3‐month (HR [95% CI], 0.87 [0.82–0.93]; P<0.001) and change in PAQ (HR [95% CI], 0.92 [0.85–0.99]; P=0.021) were each associated with mortality. In fully adjusted models including combination of scores, 3‐month PAQ was more strongly associated with mortality than either baseline (3‐month HR [95% CI], 0.85 [0.78–0.92]; P<0.001; C‐statistic, 0.77) or change (3‐month HR [95% CI], 0.79 [0.72–0.87]; P<0.001). Conclusions PAD‐specific health status is independently associated with 5‐year survival in patients with new or worsening PAD symptoms, with the most recent assessment being most prognostic. Future work is needed to better understand how this information can be used proactively to optimize care.https://www.ahajournals.org/doi/10.1161/JAHA.121.022232health statusmortalityperipheral artery disease
spellingShingle Andy T. Tran
John A. Spertus
Carlos I. Mena‐Hurtado
Philip G. Jones
Herbert D. Aronow
David M. Safley
Ali O. Malik
Poghni A. Peri‐Okonny
Mehdi H. Shishehbor
Clementine Labrosciano
Kim G. Smolderen
Association of Disease‐Specific Health Status With Long‐Term Survival in Peripheral Artery Disease
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
health status
mortality
peripheral artery disease
title Association of Disease‐Specific Health Status With Long‐Term Survival in Peripheral Artery Disease
title_full Association of Disease‐Specific Health Status With Long‐Term Survival in Peripheral Artery Disease
title_fullStr Association of Disease‐Specific Health Status With Long‐Term Survival in Peripheral Artery Disease
title_full_unstemmed Association of Disease‐Specific Health Status With Long‐Term Survival in Peripheral Artery Disease
title_short Association of Disease‐Specific Health Status With Long‐Term Survival in Peripheral Artery Disease
title_sort association of disease specific health status with long term survival in peripheral artery disease
topic health status
mortality
peripheral artery disease
url https://www.ahajournals.org/doi/10.1161/JAHA.121.022232
work_keys_str_mv AT andyttran associationofdiseasespecifichealthstatuswithlongtermsurvivalinperipheralarterydisease
AT johnaspertus associationofdiseasespecifichealthstatuswithlongtermsurvivalinperipheralarterydisease
AT carlosimenahurtado associationofdiseasespecifichealthstatuswithlongtermsurvivalinperipheralarterydisease
AT philipgjones associationofdiseasespecifichealthstatuswithlongtermsurvivalinperipheralarterydisease
AT herbertdaronow associationofdiseasespecifichealthstatuswithlongtermsurvivalinperipheralarterydisease
AT davidmsafley associationofdiseasespecifichealthstatuswithlongtermsurvivalinperipheralarterydisease
AT aliomalik associationofdiseasespecifichealthstatuswithlongtermsurvivalinperipheralarterydisease
AT poghniaperiokonny associationofdiseasespecifichealthstatuswithlongtermsurvivalinperipheralarterydisease
AT mehdihshishehbor associationofdiseasespecifichealthstatuswithlongtermsurvivalinperipheralarterydisease
AT clementinelabrosciano associationofdiseasespecifichealthstatuswithlongtermsurvivalinperipheralarterydisease
AT kimgsmolderen associationofdiseasespecifichealthstatuswithlongtermsurvivalinperipheralarterydisease